1.         Treloar, A.E., et al., Variation of the human menstrual cycle through reproductive life. Int J Fertil, 1967. 12(1 Pt 2): p. 77-126.

2.         Vollman, R.F., The Menstrual Cycle. 1977, WB Saunders: Philadelphia.

3.         Presser, H.B., Temporal data relating to the human menstrual cycle, in Biorhythms and Human Reproduction, M. Ferin, et al., Editors. 1974, John Wiley and Sons: New York. p. 145-160.

4.         Hallberg, L., et al., Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand, 1966. 45(3): p. 320-351.

5.         Apter, D., et al., Follicular growth in relation to serum hormonal patterns in adolescent compared with adult menstrual cycles. Fertil Steril, 1987. 47(1): p. 82-88.

6.         Fraser, I.S., et al., Pituitary gonadotropins and ovarian function in adolescent dysfunctional uterine bleeding. J Clin Endocrinol Metab, 1973. 37(3): p. 407-414.

7.         Lenton, E.A., et al., Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol, 1984. 91(7): p. 681-684.

8.         Groome, N.P., et al., Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab, 1996. 81(4): p. 1401-1405.

9.         Welt, C.K., et al., Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab, 2003. 88(4): p. 1766-1771.

10.       Tsafriri, A., Local nonsteroidal regulators of ovarian function, in The physiology of reproduction, E. Knobil, J.D. Neill, and et al., Editors. 1994, Raven: New York. p. 817-860.

11.       Sawetawan, C., et al., Inhibin and activin differentially regulate androgen production and 17 alpha-hydroxylase expression in human ovarian thecal-like tumor cells. J Endocrinol, 1996. 148(2): p. 213-221.

12.       Welt, C.K., et al., Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab, 1997. 82(8): p. 2645-2652.

13.       Durlinger, A.L., et al., Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology, 1999. 140(12): p. 5789-96.

14.       Hampl, R., M. Snajderova, and T. Mardesic, Antimullerian hormone (AMH) not only a marker for prediction of ovarian reserve. Physiol Res, 2011. 60(2): p. 217-23.

15.       Amsterdam, A. and S. Rotmensch, Structure-function relationships during granulosa cell differentiation. Endocr.Rev, 1987. 8(3): p. 309-337.

16.       Nimrod, A., G.F. Erickson, and K.J. Ryan, A specific FSH receptor in rat granulosa cells: properties of binding in vitro. Endocrinology, 1976. 98(1): p. 56-64.

17.       Fink, G., Gonadotropin secretion and its control, in The physiology of reproduction, E. Knobil, J.D. Neill, and et al., Editors. 1988, Raven: New York. p. 1349-1377.

18.       Zeleznik, A.J., A.R. Midgley, Jr., and L.E. Reichert, Jr., Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology, 1974. 95(3): p. 818-825.

19.       Erickson, G.F., C. Wang, and A.J. Hsueh, FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature, 1979. 279(5711): p. 336-338.

20.       McNatty, K.P., et al., Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to reductase and aromatase activity. Steroids, 1979. 34(4): p. 429-443.

21.       Young, J.R. and R.B. Jaffe, Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol. J Clin Endocrinol Metab, 1976. 42(3): p. 432-442.

22.       Reame, N., et al., Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. J Clin Endocrinol Metab, 1984. 59(2): p. 328-337.

23.       Zhou, J. and C. Bondy, Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod, 1993. 48(3): p. 467-482.

24.       Maruo, T., et al., Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology, 1993. 132(2): p. 924-931.

25.       Thierry van Dessel, H.J., et al., Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. J Clin Endocrinol Metab, 1996. 81(3): p. 1224-31.

26.       Hillier, S.G., et al., Intraovarian sex steroid hormone interactions and the regulation of follicular maturation: aromatization of androgens by human granulosa cells in vitro. J Clin Endocrinol Metab, 1980. 50(4): p. 640-647.

27.       Pauerstein, C.J., et al., Temporal relationships of estrogen, progesterone, and luteinizing hormone levels to ovulation in women and infrahuman primates. Am J Obstet Gynecol, 1978. 130(8): p. 876-886.

28.       Cahill, D.J., et al., Onset of the preovulatory luteinizing hormone surge: diurnal timing and critical follicular prerequisites. Fertil Steril, 1998. 70(1): p. 56-59.

29.       Hoff, J.D., M.E. Quigley, and S.S. Yen, Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab, 1983. 57(4): p. 792-796.

30.       Channing, C.P., et al., Ovarian follicular and luteal physiology, in International Review of Physiology, R.O. Greep, Editor. 1980, University Park Press: Baltimore. p. 117.

31.       Espey, L.L. and H. Lipner, Ovulation, in The Physiology of Reproduction, E. Knobil and J.D. Neill, Editors. 1994, Raven: New York. p. 725.

32.       Espey, L.L., Ovarian proteolytic enzymes and ovulation. Biol Reprod, 1974. 10(2): p. 216-235.

33.       Lousse, J.C. and J. Donnez, Laparoscopic observation of spontaneous human ovulation. Fertil Steril, 2008. 90(3): p. 833-834.

34.       Fukuda, M., et al., Right-sided ovulation favours pregnancy more than left-sided ovulation. Hum Reprod, 2000. 15(9): p. 1921-1926.

35.       Lumsden, M.A., et al., Changes in the concentration of prostaglandins in preovulatory human follicles after administration of hCG. J Reprod Fertil, 1986. 77(1): p. 119-124.

36.       Espey, L.L., et al., Ovarian hydroxyeicosatetraenoic acids compared with prostanoids and steroids during ovulation in rats. Am J Physiol., 1991. 260(2 Pt 1): p. E163-E169.

37.       Sherman, B.M., J.H. West, and S.G. Korenman, The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab, 1976. 42(4): p. 629-636.

38.       O'Grady, J.P., et al., The effects of an inhibitor of prostaglandin synthesis (indomethacin) on ovulation, pregnancy, and pseudopregnancy in the rabbit. Prostaglandins, 1972. 1(2): p. 97-106.

39.       Killick, S. and M. Elstein, Pharmacologic production of luteinized unruptured follicles by prostaglandin synthetase inhibitors. Fertil Steril, 1987. 47(5): p. 773-777.

40.       Pall, M., B.E. Friden, and M. Brannstrom, Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Reprod, 2001. 16(7): p. 1323-1328.

41.       Doody, K.J. and B.R. Carr, Diagnosis and treatment of luteal dysfunction, in Ovarian Endocrinology, S.G. Hillier, Editor. 1991, Blackwell Scientific: London. p. 260.

42.       Katt, J.A., et al., The frequency of gonadotropin-releasing hormone stimulation determines the number of pituitary gonadotropin-releasing hormone receptors. Endocrinology, 1985. 116(5): p. 2113-2115.

43.       Koos, R.D., Potential relevance of angiogenic factors to ovarian physiology. Semin Reprod Endocrinol, 1989. 7  p. 29.

44.       Niswender, G.D. and T.M. Nett, The corpus luteum and its control in infraprimate species, in The Physiology of Reproduction, E. Knobil and J.D. Neill, Editors. 1994, Raven: New York. p. 781.

45.       Retamales, I., et al., Morpho-functional study of human luteal cell subpopulations. Hum Reprod, 1994. 9(4): p. 591-596.

46.       Khan-Dawood, F.S., et al., Human corpus luteum secretion of relaxin, oxytocin, and progesterone. J Clin Endocrinol Metab, 1989. 68(3): p. 627-631.

47.       Carr, B.R., et al., The effect of transforming growth factor-beta on steroidogenesis and expression of key steroidogenic enzymes with a human ovarian thecal-like tumor cell model. Am J Obstet Gynecol, 1996. 174(4): p. 1109-1116.

48.       Vande Wiele, R.L., et al., Mechanisms regulating the menstrual cycle in women. Recent.Prog.Horm.Res, 1970. 26: p. 63-103.

49.       Segaloff, A., W.H. Sternberg, and C.J. Gaskill, Effects of luteotropic dose of chorionic gonadotropin in women. J Clin Endocrinol Metab, 1951. 11(9): p. 936-944.

50.       Filicori, M., J.P. Butler, and W.F. Crowley, Jr., Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest, 1984. 73(6): p. 1638-1647.

51.       McNeely, M.J. and M.R. Soules, The diagnosis of luteal phase deficiency: a critical review. Fertil Steril, 1988. 50(1): p. 1-15.

52.       Stouffer, R.L. and G.D. Hodgen, Induction of luteal phase defects in rhesus monkeys by follicular fluid administration at the onset of the menstrual cycle. J Clin Endocrinol Metab, 1980. 51(3): p. 669-671.

53.       Sheehan, K.L., R.F. Casper, and S.S. Yen, Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control. Science, 1982. 215(4529): p. 170-172.

54.       Keyes, P.L. and M.C. Wiltbank, Endocrine regulation of the corpus luteum. Annu.Rev Physiol., 1988. 50: p. 465-482.

55.       Cooke, I.D., The corpus luteum. Hum Reprod, 1988. 3(2): p. 153-156.

56.       Auletta, F.J. and A.P. Flint, Mechanisms controlling corpus luteum function in sheep, cows, nonhuman primates, and women especially in relation to the time of luteolysis. Endocr.Rev, 1988. 9(1): p. 88-105.

57.       Hodgen, G.D., Surrogate embryo transfer combined with estrogen-progesterone therapy in monkeys. Implantation, gestation, and delivery without ovaries. JAMA, 1983. 250(16): p. 2167-2171.

58.       Gore, B.Z., B.V. Caldwell, and L. Speroff, Estrogen-induced human luteolysis. J Clin Endocrinol Metab, 1973. 36(3): p. 615-617.

59.       Iwai, T., et al., Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle. Virchows Arch A Pathol Anat Histopathol, 1990. 417(5): p. 369-375.

60.       Wentz, A.C. and G.S. Jones, Transient luteolytic effect of prostaglandin F2alpha in the human. Obstet Gynecol, 1973. 42(2): p. 172-181.

61.       Schoonmaker, J.N., et al., Estradiol-induced luteal regression in the rhesus monkey: evidence for an extraovarian site of action. Endocrinology, 1982. 110(5): p. 1708-1715.

62.       Shikone, T., et al., Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. J Clin Endocrinol Metab, 1996. 81(6): p. 2376-2380.

63.       Khan-Dawood, F.S., J.C. Huang, and M.Y. Dawood, Baboon corpus luteum oxytocin: an intragonadal peptide modulator of luteal function. Am J Obstet Gynecol, 1988. 158(4): p. 882-891.

64.       Young, K.A., J.D. Hennebold, and R.L. Stouffer, Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Mol Hum Reprod, 2002. 8(9): p. 833-840.

65.       Judd, H.L. and S.S. Yen, Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab, 1973. 36(3): p. 475-481.

66.       Genazzani, A.R., et al., Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle. J Clin Endocrinol Metab, 1975. 41(3): p. 431-437.

67.       Carr, B.R., et al., Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. J Clin Endocrinol Metab, 1979. 49(3): p. 346-349.

68.       Carr, B.R. and J.D. Wilson, Disorders of the ovary and the female reproductive tract, in Harrison's Principles of Internal Medicine, E. Braunwald, et al., Editors. 1987, McGraw-Hill: New York. p. 1818.

69.       Casey, M.L. and P.C. MacDonald, Extraadrenal formation of a mineralocorticosteroid: deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism. Endocr.Rev, 1982. 3(4): p. 396-403.

70.       Parker, C.R., Jr., et al., Plasma concentrations of 11-deoxycorticosterone in women during the menstrual cycle. Obstet Gynecol, 1981. 58(1): p. 26-30.

71.       Noyes, R.W., A.T. Hertig, and J. Rock, Dating the endometrial biopsy. Am J Obstet Gynecol, 1975. 122(2): p. 262-263.

72.       Lessey, B.A., et al., Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab, 1988. 67(2): p. 334-340.

73.       Tseng, L. and H.C. Liu, Stimulation of arylsulfotransferase activity by progestins in human endometrium in vitro. J Clin Endocrinol Metab, 1981. 53(2): p. 418-421.

74.       Rebar, R.E., Practical evaluation of hormonal status, in Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management, S.S.C. Yen and R.B. Jaffe, Editors. 1991, WB Saunders: Philadelphia. p. 830.

75.       Gaudefroy, M., Cytologic criteria of estrogen effect. Acta Cytol, 1958(2): p. 347.

76.       Henzl, M.R., et al., Lysosomal concept of menstrual bleeding in humans. J Clin Endocrinol Metab, 1972. 34(5): p. 860-875.

77.       Turksoy, R.N. and H.S. Safaii, Immediate effect of prostaglandin F2alpha during the luteal phase of the menstrual cycle. Fertil Steril, 1975. 26(7): p. 634-637.

78.       Edman, C.D., The effects of steroids on the endometrium. Semin Reprod Endocrinol, 1983. 1(3): p. 179.

79.       Curry, T.E., Jr. and K.G. Osteen, Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod, 2001. 64(5): p. 1285-1296.

80.       Cutolo, M., Gender and the rheumatic diseases: Epidemiological evidence and possible biologic mechanisms. Annals of the Rheumatic Diseases, 2003. 62: p. 3-3.

81.       Anker, J.J. and M.E. Carroll, Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci, 2011. 8: p. 73-96.